StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Vertex (VRTX) is a Clean Revenue Growth Story, Pipeline is Discounted and Stock Remains Preferred - BMO Capital
January 26, 2022 4:46 PM
BMO Capital analyst Evan David Seigerman reiterated an Outperform rating and $274.00 price target on Vertex (NASDAQ: VRTX), following recent ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Trader Talk
Next Articles
Vertex Pharma (VRTX) Tops Q4 EPS by 8c, Offers Guidance
January 26, 2022 4:04 PM